Rigel Pharmaceuticals, Inc. financial statements, including revenue, expenses, profit, and loss

The total revenue of RIGL for the last quarter is 35.79 M USD, and it's 27.22% higher compared to the previous quarter. The net income of Q4 23 is 737.00 k USD.